SCHEMBL18281736

SCHEMBL18281736

CC(C)(C)OC(=O)Nc1ccc(C=NN)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MIF P14174 1/20 0.51
▸ NPC1 O15118 4/20 0.50
▸ RAB9A P51151 4/20 0.50
▸ RECQL P46063 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ MAPT P10636 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.48
▸ CYP17A1 P05093 2/20 0.46
▸ PSMB8 P28062 1/20 0.44
▸ NAMPT P43490 1/20 0.44
▸ MAP4K4 O95819 1/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18288123 1.00 MIF (0.51) MIFNPC1RAB9ARECQLSMN1; SMN2
SCHEMBL18281734 1.00 MIF (0.51) MIFNPC1RAB9ARECQLSMN1; SMN2
SCHEMBL21339831 0.86 MIF (0.52) MIFNPC1RAB9ARECQLSMN1; SMN2
SCHEMBL31341175 0.86 MIF (0.52) MIFNPC1RAB9ARECQLSMN1; SMN2
SCHEMBL7372333 0.86 MIF (0.52) MIFNPC1RAB9ARECQLSMN1; SMN2
SCHEMBL2744305 0.86 MIF (0.52) MIFNPC1RAB9ARECQLSMN1; SMN2
SCHEMBL13055402 0.82 CYP17A1 (0.59) SMN1; SMN2CYP17A1PSMB8NAMPTMAP4K4
SCHEMBL418939 0.81 CYP17A1 (0.54) MIFNPC1RAB9ARECQLSMN1; SMN2
SCHEMBL1672145 0.80 CYP17A1 (0.49) MIFNPC1RAB9ARECQLSMN1; SMN2
SCHEMBL596258 0.78 HDAC3 (0.50) MIFNPC1RAB9ARECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303285-B1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-02-19 — — EP disclosed
EP-3303285-B1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-02-19 — — EP disclosed
US-10336691-B2 Pesticidally active oxime and hydrazone derivatives SYNGENTA PARTICIPATIONS AG (CH) 2019-07-02 — — US disclosed
US-10336691-B2 Pesticidally active oxime and hydrazone derivatives SYNGENTA PARTICIPATIONS AG (CH) 2019-07-02 — — US disclosed
US-20180141898-A1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2018-05-24 — — US disclosed
US-20180141898-A1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2018-05-24 — — US disclosed
US-20180141898-A1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2018-05-24 — — US disclosed
EP-3303285-A1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES Syngenta Participations AG (CH) 2018-04-11 — — EP disclosed
WO-2016193284-A1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-12-08 — — WO disclosed
WO-2016193284-A1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-12-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141898-A1 PESTICIDALLY ACTIVE OXIME AND HYDRAZONE DERIVATIVES ACHE, CAT, DDT MIF 1780/4885NPC1 4360/4885RAB9A 1412/4885
US-10336691-B2 Pesticidally active oxime and hydrazone derivatives ACHE, CAT, DDT MIF 1780/4885NPC1 4360/4885RAB9A 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback